Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Director/PDMR Shareholding

6 Jan 2025 11:54

RNS Number : 2730S
Marlowe PLC
06 January 2025
 

6 January 2025

 

Marlowe plc

("Marlowe or the "Company")

 

Director/PDMR Shareholding

 

Marlowe plc ("Marlowe", the "Group" or the "Company"), the leader in business-critical services, announces that on 2 January 2025 Robert Flinn, Chief Executive Officer of Marlowe's Fire Division, and his spouse purchased an aggregate of 15,527 ordinary shares of 50 pence each in the capital of the Company ("Ordinary Shares") at a weighted average price of 319.94 pence per Ordinary Share.

Following the purchases, Robert Flinn is now beneficially interested in 88,082 Ordinary Shares, representing 0.11 per cent. of the Company's issued share capital, of which 23,319 Ordinary Shares are held by his wife.

The notifications below, made in accordance with the UK Market Abuse Regulation, provide further details.

For further information:

 

 

 

Marlowe plc

Lord Ashcroft, Interim Non-Executive Chair

Adam Councell, Chief Financial Officer

Benjamin Tucker, Head of Investor Relations & Strategy

www.marloweplc.com

Tel: +44 (0)20 3813 8498

IR@marloweplc.com

 

Cavendish Capital Markets Limited (Nominated Adviser & Broker)

Ben Jeynes

George Lawson

Tel: +44 (0)20 7220 0500

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Flinn

2

Reason for the notification

a)

Position/status

PDMR, CEO of Fire Division

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Purchase of ordinary shares

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

319.90 pence

9,316

d)

 

Aggregated information

 N/A single transaction

- Aggregated volume

- Price

e)

Date of the transaction

2 January 2025

 

f)

Place of the transaction

AIMX

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Claire Flinn

2

Reason for the notification

a)

Position/status

PCA of Robert Flinn, PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Purchase of ordinary shares

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

320.00 pence

6,211

d)

 

Aggregated information

 N/A single transaction

- Aggregated volume

- Price

e)

Date of the transaction

2 January 2025

 

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGGMMVFGKZM
Date   Source Headline
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:51 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSPublication of Notice of AGM and Annual Report
9th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20248:18 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20242:52 pmRNSHolding(s) in Company
22nd Jul 202412:51 pmRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSNotice of Full Year Results
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20242:55 pmRNSHolding(s) in Company
17th Jul 20247:01 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20243:04 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20245:31 pmRNSTransaction in Own Shares
5th Jul 20245:46 pmRNSTransaction in Own Shares
13th Jun 20243:38 pmRNSHolding(s) in Company
3rd Jun 20247:00 amRNSDivestment, Special Dividend & Board Changes
23rd May 20245:27 pmRNSDirector/PDMR Shareholding & Holding(s) in Company
23rd May 20242:49 pmRNSExercise of Share Options & Total Voting Rights
22nd May 20247:00 amRNSTrading Update
14th May 20247:00 amRNSChange of Advisers
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.